This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2020 Jan;71(1):383-385.

doi: 10.1002/hep.30874. Epub 2019 Oct 10.

Apolipoprotein B and PNPLA3 Double Heterozygosity in a Father-Son Pair With Advanced Nonalcoholic Fatty Liver Disease

Claire L Jansson-Knodell¹, Samer Gawrieh¹, Adam D McIntyre², Tiebing Liang¹, Robert A Hegele², Naga Chalasani¹

Affiliations

Affiliations

¹ Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, IN.
² Robarts Research Institute, London, Ontario, Canada.

PMID: 31343751
DOI: 10.1002/hep.30874

Free article

Case Reports

Apolipoprotein B and PNPLA3 Double Heterozygosity in a Father-Son Pair With Advanced Nonalcoholic Fatty Liver Disease

Claire L Jansson-Knodell et al. Hepatology. 2020 Jan.

Free article

. 2020 Jan;71(1):383-385.

doi: 10.1002/hep.30874. Epub 2019 Oct 10.

Authors

Claire L Jansson-Knodell¹, Samer Gawrieh¹, Adam D McIntyre², Tiebing Liang¹, Robert A Hegele², Naga Chalasani¹

Affiliations

¹ Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, IN.
² Robarts Research Institute, London, Ontario, Canada.

PMID: 31343751
DOI: 10.1002/hep.30874

No abstract available

PubMed Disclaimer

Similar articles

Validating a non-invasive, ALT-based non-alcoholic fatty liver phenotype in the million veteran program.
Serper M, Vujkovic M, Kaplan DE, Carr RM, Lee KM, Shao Q, Miller DR, Reaven PD, Phillips LS, O'Donnell CJ, Meigs JB, Wilson PWF, Vickers-Smith R, Kranzler HR, Justice AC, Gaziano JM, Muralidhar S, Pyarajan S, DuVall SL, Assimes TL, Lee JS, Tsao PS, Rader DJ, Damrauer SM, Lynch JA, Saleheen D, Voight BF, Chang KM; VA Million Veteran Program. Serper M, et al. PLoS One. 2020 Aug 25;15(8):e0237430. doi: 10.1371/journal.pone.0237430. eCollection 2020. PLoS One. 2020. PMID: 32841307 Free PMC article.
Association of polymorphisms in GCKR and TRIB1 with nonalcoholic fatty liver disease and metabolic syndrome traits.
Kitamoto A, Kitamoto T, Nakamura T, Ogawa Y, Yoneda M, Hyogo H, Ochi H, Mizusawa S, Ueno T, Nakao K, Sekine A, Chayama K, Nakajima A, Hotta K. Kitamoto A, et al. Endocr J. 2014;61(7):683-9. doi: 10.1507/endocrj.ej14-0052. Epub 2014 May 1. Endocr J. 2014. PMID: 24785259
Genetic Susceptibility to Chronic Liver Disease in Individuals from Pakistan.
Raja AM, Ciociola E, Ahmad IN, Dar FS, Naqvi SMS, Moaeen-Ud-Din M, Kaukab Raja G, Romeo S, Mancina RM. Raja AM, et al. Int J Mol Sci. 2020 May 18;21(10):3558. doi: 10.3390/ijms21103558. Int J Mol Sci. 2020. PMID: 32443539 Free PMC article.
Genetics of Nonalcoholic Fatty Liver Disease: A 2018 Update.
Valenti LVC, Baselli GA. Valenti LVC, et al. Curr Pharm Des. 2018;24(38):4566-4573. doi: 10.2174/1381612825666190119113836. Curr Pharm Des. 2018. PMID: 30659533 Review.
Genetic predisposition in nonalcoholic fatty liver disease.
Sookoian S, Pirola CJ. Sookoian S, et al. Clin Mol Hepatol. 2017 Mar;23(1):1-12. doi: 10.3350/cmh.2016.0109. Epub 2017 Mar 9. Clin Mol Hepatol. 2017. PMID: 28268262 Free PMC article. Review.

See all similar articles

Cited by

Low LDL Cholesterol Is Not an Independent Risk Factor for Hepatic Steatosis.
McHenry S, Awad A, Kozlitina J, Stitziel NO, Davidson NO. McHenry S, et al. Dig Dis Sci. 2023 Aug;68(8):3451-3457. doi: 10.1007/s10620-023-07980-8. Epub 2023 Jun 8. Dig Dis Sci. 2023. PMID: 37291473
Genetics, Immunity and Nutrition Boost the Switching from NASH to HCC.
Dongiovanni P, Meroni M, Longo M, Fargion S, Fracanzani AL. Dongiovanni P, et al. Biomedicines. 2021 Oct 23;9(11):1524. doi: 10.3390/biomedicines9111524. Biomedicines. 2021. PMID: 34829753 Free PMC article. Review.
Interrogation of selected genes influencing serum LDL-Cholesterol levels in patients with well characterized NAFLD.
Vilar-Gomez E, Gawrieh S, Liang T, McIntyre AD, Hegele RA, Chalasani N. Vilar-Gomez E, et al. J Clin Lipidol. 2021 Mar-Apr;15(2):275-291. doi: 10.1016/j.jacl.2020.12.010. Epub 2020 Dec 27. J Clin Lipidol. 2021. PMID: 33454241 Free PMC article.

References

1. Della Corte C, Fintini D, Giordano U, Cappa M, Brufani C, Majo F, et al. Fatty liver and insulin resistance in children with hypobetalipoproteinemia: the importance of aetiology. Clin Endocrinol (Oxf) 2013;79:49-54.
1. Yue P, Yuan B, Gerhard DS, Neuman RJ, Isley WL, Harris WS, et al. Novel mutations of APOB cause ApoB truncations undetectable in plasma and familial hypobetalipoproteinemia. Hum Mutat 2002;20:110-116.
1. Eslam M, Valenti L, Romeo S. Genetics and epigenetics of NAFLD and NASH: clinical impact. J Hepatol 2018;68:268-279.
1. Dongiovanni P, Stender S, Pietrelli A, Mancina RM, Cespiati A, Petta S, et al. Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver. J Intern Med 2018;283:356-370.
1. Pelusi S, Baselli G, Pietrelli A, Dongiovanni P, Donati B, McCain MV, et al. Rare pathogenic variants predispose to hepatocellular carcinoma in nonalcoholic fatty liver disease. Sci Rep 2019;9:3682.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information